Virtual Clinical Trials
Virtual clinical trials (VCTs) are site-less clinical trials, which utilizes technology along with the inclusion of web platforms for recruitment, counseling, measurement of endpoints, adverse reaction study, and many such procedures that are followed during a traditional clinical trial; allowing the patients to be home-based at every stage of the clinical trial. VCTs are cost-effective, faster, with better retention rates, have good demographic representation and, are time-saving trials. There are few limitations associated with virtual trials such as it is restricted for life-threatening diseases or one that require large procedures such as biopsies, high imaging systems capital equipment such as MRI cannot be performed as virtual trials.
Through this whitepaper, DelveInsight is representing the current scenario of virtual clinical trial in the pharmaceutical and medical device industry. The whitepaper includes an overview, comparison between traditional and virtual clinical trial, impact of COVID-19 on clinical trial, past and on-going virtual clinical trial, major services provider, and conclusion. The virtual clinical trials are helping companies and patients to conduct clinical trial without visiting the site, reducing the cost, monitor their vitals independently and remotely, thus, having better retention rate. The key providers of VCTs solutions are Obvio Health USA, Inc., CLINPAL, VIRTRIAL, Lightship, Medable, Science 37, Parexel International Corporation, Medidata, PRA Health, and Curavit Clinical Research, among others. VCT has made it easier to conduct clinical trials in the time of pandemic when patients can't travel to clinical trial locations due to restrictions in movement to curb the virus spread. It will bring in a new future of remote accessibility, affordability, and more flexible implementation of clinical studies by taking the clinical trial research on the patients' doorstep.
